Calyxt Investor Relations Material

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company operates through Plant Products segment. It develops and commercializes naturally occurring microbial products to produce insect resistant maize hybrids and herbicide tolerant soybeans for corn and soybean crops, each of which require no additional applications of chemical pesticides or fertilizers; and its Nexera product line containing canola sorghum hybrids that are tolerant to both herbicides and abiotic stresses around the globe. The company also focuses on developing these products using its gene editing technology platform, Cibus-Tooker DNA editing system.